K243188 is an FDA 510(k) clearance for the CYLOX® ST. This device is classified as a Intervertebral Fusion Device With Integrated Fixation, Cervical (Class II - Special Controls, product code OVE).
Submitted by Signus Medizintechnik GmbH (Alzenau, DE). The FDA issued a Cleared decision on February 11, 2025, 134 days after receiving the submission on September 30, 2024.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation..